Tadalafil dosage forms and strengths

Revision as of 22:18, 7 February 2014 by Pratik Bahekar (talk | contribs) (Created page with "__NOTOC__ {{Tadalafil}} {{CMG}}; {{AE}} {{PB}} '''''For patient information, click <u>here'''''</u> ==Dosage Forms and Strengths...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Tadalafil
ADCIRCA (tadalafil) tablet ® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here

Dosage Forms and Strengths

[1]

References

  1. ↑ "ADCIRCA (TADALAFIL) TABLET [UNITED THERAPEUTICS CORPORATION]". Retrieved 7 February 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=Tadalafil_dosage_forms_and_strengths&oldid=940426"